Storys zum Thema Medizin, Gesundheit
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- Ein Dokumentmehr
Free Access to Cancer Research Services - canSERV 1st Call for Proposals
Ein DokumentmehrInnovation and Start-up Center Biotechnology (IZB) welcomes Invitris
Ein DokumentmehrTime makes the difference, PI 16/2023
Time makes the difference About 18,000 physicians from Cuba came to Brazil between 2013 and 2018 during the "More Doctors for Brazil" project. The programme aimed at alleviating the public health emergency, however, initially met with surprising resistance, as Konstanz anthropologist Maria Lidola observed in Rio de Janeiro. When countries in the Global ...
Ein DokumentmehrPress release: EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) - Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) ...
Ein DokumentmehrPress release: Adalvo and STADA extend their strategic partnership
Adalvo and STADA extend their strategic partnership - Strategic partnership in Europe extended to cover five additional molecules in therapeutic categories including oncology and diabetes - Adalvo CEO Anil Okay: “These new agreements demonstrate the significance of the strategic partnership we have built with STADA, in the last couple of years. We take ...
Ein DokumentmehrPress release: STADA appoints Boris Döbler as Chief Financial Officer
Ein DokumentmehrPress release: Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe
Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe - Launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe - Follows initial introduction of adalimumab in ninecountries: ...
Ein DokumentmehrGerresheimer to expand significantly in High Value Solutions and further accelerates its sustainable profitable growth
Düsseldorf (ots) - At today’s Capital Markets Day, Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted ...
Ein Dokumentmehr- 3
Press release: STADA starts work on >EUR50m facility to strengthen European medicines supply
Ein Dokumentmehr Press release: Stéphane Jacqmin joins STADA from Sanofi and becomes Head of Emerging Markets
Ein DokumentmehrPress release: STADA and Xbrane secure EU approval for Ximluci® (ranibizumab) biosimilar referencing Lucentis®
STADA and Xbrane secure EU approval for Ximluci® (ranibizumab) biosimilar referencing Lucentis® - European Commission grants pan-EU marketing authorization for Ximluci® biosimilar referencing Lucentis® (ranibizumab) - Paves way for European ...
Ein Dokumentmehr- 5
Press Release - hubergroup India supports rural areas with medical vans
Ein Dokumentmehr Gerresheimer reports double digit growth in revenue and earnings for the third quarter
Duesseldorf (ots) - - Organic revenue growth of 17.4% in the third quarter supported by continued strong demand for High Value Solutions - Organic adjusted EBITDA up 13.3% - Gerresheimer firmly on track to deliver on FY 2022 guidance Gerresheimer AG, a leading provider of healthcare & beauty solutions ...
Ein DokumentmehrPress release: STADA sets standard in Specialty by launching the first medicine authorized in the EU for treating rare kidney disease
STADA sets standard in Specialty by launching the first medicine authorized in the EU for treating rare kidney disease - Germany is STADA’s lead launch market for EU’s first authorized treatment for a rare kidney disease immunoglobulin A ...
Ein DokumentmehrPress release: Strong in-market performance leads STADA to double-digit growth
Strong in-market performance leads STADA to double-digit growth - Continued strong organic market-share gains across key European markets, supported by several launches - Adjusted Group sales advance by 15% while adjusted EBITDA improve by 23% in first half of 2022 - STADA CEO Peter Goldschmidt: “In ...
Ein Dokumentmehr- 6
Press release: Aurubis plants in Hamburg and Lünen receive internationally recognized Copper Mark quality seal
Ein Dokumentmehr Press release: STADA welcomes EU approval of Kinpeygo® for adults with primary IgA nephropathy
STADA welcomes EU approval of Kinpeygo® for adults with primary IgA nephropathy - The European Commission (EC) has granted conditional marketing authorization for Kinpeygo® for the treatment of primary immunoglobulin A (IgA) nephropathy (IgAN) in adults at risk of rapid disease progression with a ...
Ein DokumentmehrGerresheimer on track to deliver record financial year 2022 after solid second quarter
Ein DokumentmehrSTADA Health Report 2022: Europe experiencing worsening health conditions
STADA Health Report 2022: Europe experiencing worsening health conditions - Self-assessed burnout rates at all-time high; stress levels have increased; more than one in three are struggling with sleep; appreciation for healthcare systems decreases after Covid high - STADA Health Report 2022: ...
Ein Dokumentmehr- 3
Press release: Maintenance shutdown at Aurubis plant in Hamburg completed successfully
Ein Dokumentmehr Press release: STADA and Alvotech broaden European patients’ options by launching a high-concentration, citrate-free adalimumab
STADA and Alvotech broaden European patients’ options by launching a high-concentration, citrate-free adalimumab - Offers a comprehensive range of presentations to the EU adalimumab biosimilars market - Adalimumab marks the first molecule ...
Ein Dokumentmehr- 2
Press release: Investment in the future: major planned maintenance shutdown at Aurubis' plant in Hamburg
Ein Dokumentmehr Innovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.Bio
Ein DokumentmehrBrenntag announces new agreement with Corbion for Animal Nutrition in Belgium, The Netherlands and France
Ein DokumentmehrBrenntag’s Larry Davis on serving major trends in the Nutrition industry
Ein DokumentmehrBrenntag’s Pharma section signs exclusive agreement for health-promoting product line Akovita ELIP in EMEA
Ein DokumentmehrBrenntag invests in its Animal Nutrition production unit in Kędzierzyn-Koźle, Poland
Ein Dokumentmehr- 4
RTL Donation Marathon: Einhell offers support to children suffering from cancer
Ein Dokumentmehr - 2
The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics
Ein Dokumentmehr